Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • jgarush jgarush Jul 30, 1999 5:05 PM Flag

    News release

    SAN DIEGO, Calif., July 30 (dbusiness) �
    Neurocrine Biosciences Inc. will be initiating a new phase
    of testing for its insomnia product.

    The
    phase II clinical study will assess the safety of the
    product in a laboratory setting among approximately 228
    patients. Phase I testing found the product to be �safe and
    well tolerated� among healthy volunteers, according to
    the company.


    Jamie

 
NBIX
53.94-0.22(-0.41%)Sep 23 4:00 PMEDT